These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2876444)

  • 1. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction between macromolecular adjuvants and drugs. 25. The effect of cellulose ether on the solubility characteristics of benzodiazepine derivatives].
    Keipert S; Alde D
    Pharmazie; 1986 Dec; 41(12):845-9. PubMed ID: 2883673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility of selected derivatives of 1,4-benzodiazepine-2-one in the presence of PVP.
    Cwiertnia B
    Acta Pol Pharm; 2008; 65(4):487-91. PubMed ID: 19051592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.
    Martínez-Ohárriz MC; Rodríguez-Espinosa C; Martín C; Goñi MM; Tros-Ilarduya MC; Sánchez M
    Drug Dev Ind Pharm; 2002 Jul; 28(6):717-25. PubMed ID: 12149965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide.
    Corrigan OI; Timoney RF
    J Pharm Pharmacol; 1975 Oct; 27(10):759-64. PubMed ID: 241789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphous spray-dried hydroflumethiazide-polyvinylpyrrolidone systems: physiochemical properties.
    Corrigan OI; Holohan EM
    J Pharm Pharmacol; 1984 Apr; 36(4):217-21. PubMed ID: 6144766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Physicochemical Investigation of 17β-Estradiol Crystalline Prepared by In Situ pH-Dependent Solubility Technique with Polyvinylpyrrolidone.
    Xiong H; Fu J; Sun H; Wang E; Ding Y; Ren G; Jing Q; Ren F
    AAPS PharmSciTech; 2017 Nov; 18(8):2889-2897. PubMed ID: 28424978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the aqueous solubility of acetaminophen in the presence of polyvinylpyrrolidone and investigation of the mechanisms involved.
    Garekani HA; Sadeghi F; Ghazi A
    Drug Dev Ind Pharm; 2003 Feb; 29(2):173-9. PubMed ID: 12648014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulometric determination of the effect of polyvinylpyrrolidone on the dissolution rates of difficultyly soluble drugs (author's transl)].
    Voigt R; Terborg D
    Pharmazie; 1980; 34(5-6):311-2. PubMed ID: 7413707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of baicalin-poly -vinylpyrrolidone coprecipitate.
    Li B; Wen M; Li W; He M; Yang X; Li S
    Int J Pharm; 2011 Apr; 408(1-2):91-6. PubMed ID: 21291971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.
    Kanaze FI; Kokkalou E; Niopas I; Barmpalexis P; Georgarakis E; Bikiaris D
    Drug Dev Ind Pharm; 2010 Mar; 36(3):292-301. PubMed ID: 19663560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of drug-phospholipid coprecipitates I: Physical properties and dissolution behavior of griseofulvin-dimyristoylphosphatidylcholine systems.
    Venkataram S; Rogers JA
    J Pharm Sci; 1984 Jun; 73(6):757-61. PubMed ID: 6737259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of dissolution profile by solid dispersion (kneading) technique.
    Modi A; Tayade P
    AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates.
    Simonelli AP; Mehta SC; Higuchi WI
    J Pharm Sci; 1969 May; 58(5):538-49. PubMed ID: 5796439
    [No Abstract]   [Full Text] [Related]  

  • 20. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.